UnitedHealth Group Incorporated (NYSE:UNH) Stock Holdings Lessened by GUARDCAP ASSET MANAGEMENT Ltd

GUARDCAP ASSET MANAGEMENT Ltd reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 724,694 shares of the healthcare conglomerate’s stock after selling 98,005 shares during the period. UnitedHealth Group accounts for about 5.9% of GUARDCAP ASSET MANAGEMENT Ltd’s investment portfolio, making the stock its 9th largest position. GUARDCAP ASSET MANAGEMENT Ltd’s holdings in UnitedHealth Group were worth $366,594,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter worth approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on UNH. Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. Twenty equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 1.3 %

NYSE:UNH opened at $517.72 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $473.57 billion, a PE ratio of 33.40, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The business’s 50 day moving average is $510.19 and its two-hundred day moving average is $547.11.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $5.83 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.